C07H 13/10
Having the esterifying carboxyl radicals directly attached to heterocyclic rings
Official title: having the esterifying carboxyl radicals directly attached to heterocyclic rings
C07H13/10 (Having the esterifying carboxyl radicals directly attached to heterocyclic rings) appears on 87 US grants and 79 published applications in this corpus.
Search patents in C07H- Granted patents
- 87
- Published applications
- 79
- Assignees
- 70
- Inventors
- 296
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 2 |
| 2003 | 2 | 5 |
| 2004 | 0 | 3 |
| 2005 | 2 | 4 |
| 2006 | 2 | 4 |
| 2007 | 3 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 2 |
| 2011 | 1 | 3 |
| 2012 | 0 | 1 |
| 2013 | 3 | 3 |
| 2014 | 1 | 1 |
| 2015 | 4 | 3 |
| 2016 | 0 | 4 |
| 2017 | 2 | 2 |
| 2018 | 2 | 1 |
| 2019 | 2 | 6 |
| 2020 | 6 | 3 |
| 2021 | 4 | 10 |
| 2022 | 2 | 5 |
| 2023 | 2 | 4 |
| 2024 | 3 | 4 |
| 2025 | 3 | 3 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aromatic ring or heteroaromatic ring derivatives, preparation method therefor and use thereof24 Feb 2026US 12,559,449 B2Shanghai Aryl Pharmtech Co., Ltd.
- Compounds and pharmaceutical uses thereof13 Jan 2026US 12,521,410 B2SyneuRx International (Taiwan) Corp.
- Galactoside inhibitor of galectins16 Dec 2025US 12,497,428 B2Galecto Biotech AB
- Compound having neuroprotective effect, preparation method therefor and use thereof18 Nov 2025US 12,473,276 B2Shanghai Zhimeng Biopharma, Inc.
- Preparation method for high-purity granatin A14 Oct 2025US 12,441,752 B2Xinjiang Technical Institute of Physics & Chemistry, Chinese Academy of Sciences
- Interglycan esters of sucrose dicarboxylate and fructofuranuronate, process for the manufacture thereof, and use thereof as a hypoglycemic slow sugar3 Sep 2026US 2026/0258069 A1
- Interglycan esters of sucrose dicarboxylate and fructofuranuronate, process for the manufacture thereof, and use thereof as a hypoglycemic slow sugar20 Aug 2026US 2026/0242404 A1
- Phosphoramidate monosaccarides, pharmaceutical compositions, and diagnostic and therapeutic applications16 Jul 2026US 2026/0199382 A1Surio Therapeutics Co., LTD.
- Peripherally restricted gaba positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system12 Feb 2026US 2026/0042763 A1Lieber Institute, Inc.
- Molecular editing of multiple c-h bonds leveraging recognition of distance, geometry and chirality28 Aug 2025US 2025/0270187 A1The Scripps Research Institute
Most cited
By later US patents
- Orally active heparin salts containing multivalent cationic units101US 4,703,042 A1987
- Protein kinase c. modulators. d.90US 5,145,842 AAlder Research Center Limited Partnership · 1992
- Process and a composition for immunizing plants against diseases59US 4,931,581 ACiba-Geigy Corporation · 1990
- Sialyl Le.sup.x analogues as inhibitors of cellular adhesion59US 5,604,207 ACytel Corporation · 1997
- Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity55US 5,962,498 AProcyon Pharmaceuticals, Inc. · 1999